Genetic Syndromes and Congenital Heart Defects

Congenital heart defects (CHDs) represent the most prevalent class of birth anomalies, affecting approximately 1 in 100 live births worldwide. A substantial proportion of these defects arise in the context of genetic syndromes, where chromosomal imbalances or single-gene mutations disrupt normal cardiogenesis. Syndromes such as 22q11.2 deletion, Down, Turner and Alagille each carry distinct cardiac phenotypes, from septal defects to complex outflow tract malformations. Underlying mechanisms include altered gene dosage, impaired neural crest cell migration, disrupted transcriptional networks and extracellular matrix abnormalities. Advances in prenatal imaging and genomic technologies have improved early detection and informed risk stratification. Integrating molecular diagnostics with echocardiographic and surgical expertise enables personalised management pathways, from in utero interventions to staged repair and long-term surveillance. Understanding the genetic architecture of CHDs also fosters the development of novel therapies, guiding targeted modulation of developmental pathways and advancing counselling for affected families.

Research from Nature Portfolio

Recent studies have investigated TBX1 haploinsufficiency in 22q11.2 deletion syndrome. Using mouse models and human specimens, researchers have shown that reduced TBX1 dosage not only predisposes to conotruncal heart anomalies but also leads to local skeletal deformities and cerebellar dysplasia. Single-nuclei RNA sequencing identified premature differentiation of chondrocytes to osteoblasts in the petrous temporal bone, revealing an unanticipated interaction between skeletal development and neural circuitry. These findings illuminate the broader role of TBX1 in orchestrating craniofacial and cardiac morphogenesis and may inform future approaches aimed at correcting gene-dose imbalances during embryogenesis.

Genetic Syndromes and Congenital Heart Defects publication trend

The graph below shows the total number of articles in genetic syndromes and congenital heart defects across all publications each year (not limited to Nature Index journals).

Technical terms

Haploinsufficiency: A genetic circumstance in which a single functional copy of a gene does not produce enough gene product to maintain normal function.

Congenital heart defect: A structural abnormality of the heart or great vessels present at birth, encompassing septal defects, outflow tract malformations and valvular anomalies.

Microdeletion syndrome: A disorder caused by the loss of a small chromosomal segment that includes multiple neighbouring genes, often leading to multisystem involvement.

Gene dosage: The number of copies of a particular gene in a cell’s genome, which influences the quantity of the corresponding RNA and protein products.

Conotruncal defect: A subset of congenital heart defects affecting the outflow tract of the heart, such as tetralogy of Fallot, truncus arteriosus or interrupted aortic arch.

References

1. Tbx1 haploinsufficiency leads to local skull deformity, paraflocculus and flocculus dysplasia, and motor-learning deficit in 22q11.2 deletion syndrome. Nature Communications (2024).
2. Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genetics in Medicine (2023).
3. Management of adults with Alagille syndrome. Hepatology International (2023).